Show Summary Details
Page of

Cardiac transplantation and mechanical circulatory support 

Cardiac transplantation and mechanical circulatory support
Cardiac transplantation and mechanical circulatory support

Jayan Parameshwar

, and Steven Tsui

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 28 July 2021

Cardiac transplantation is the treatment of choice for selected patients with advanced heart failure: median survival approaches 12 years and recipients enjoy an excellent quality of life, but availability is severely limited by shortage of donor organs. The need for lifelong immunosuppression is associated with side effects, including an increased incidence of malignancy. Newer immunosuppressive agents reduce nephrotoxicity and delay the onset of cardiac allograft vasculopathy, but may produce other side effects. Ventricular assist devices are mechanical blood pumps that work in parallel or series with the native ventricles. First-generation volume-displacement pulsatile ventricular assist devices have been superseded by rotary blood pumps that generate continuous flow. Significant complications include bleeding, thromboembolism, device failure due to pump thrombosis, and infection.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.